Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 016807

Expand all

THYROLAR-0.25 (LIOTRIX (T4;T3))
0.0125MG;0.0031MG
Marketing Status: Discontinued

Active Ingredient: LIOTRIX (T4;T3)
Proprietary Name: THYROLAR-0.25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.0125MG;0.0031MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N016807
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

THYROLAR-0.5 (LIOTRIX (T4;T3))
0.025MG;0.0063MG
Marketing Status: Discontinued

Active Ingredient: LIOTRIX (T4;T3)
Proprietary Name: THYROLAR-0.5
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.025MG;0.0063MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N016807
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

THYROLAR-1 (LIOTRIX (T4;T3))
0.05MG;0.0125MG
Marketing Status: Discontinued

Active Ingredient: LIOTRIX (T4;T3)
Proprietary Name: THYROLAR-1
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.05MG;0.0125MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N016807
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

THYROLAR-2 (LIOTRIX (T4;T3))
0.1MG;0.025MG
Marketing Status: Discontinued

Active Ingredient: LIOTRIX (T4;T3)
Proprietary Name: THYROLAR-2
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.1MG;0.025MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N016807
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

THYROLAR-3 (LIOTRIX (T4;T3))
0.15MG;0.0375MG
Marketing Status: Discontinued

Active Ingredient: LIOTRIX (T4;T3)
Proprietary Name: THYROLAR-3
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.15MG;0.0375MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N016807
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

THYROLAR-5 (LIOTRIX (T4;T3))
0.25MG;0.0625MG
Marketing Status: Discontinued

Active Ingredient: LIOTRIX (T4;T3)
Proprietary Name: THYROLAR-5
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.25MG;0.0625MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N016807
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information